{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:21:32Z","timestamp":1771654892550,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences","award":["2019-RC-HL-001"],"award-info":[{"award-number":["2019-RC-HL-001"]}]},{"name":"the CAMS Innovation Fund for the Medical Sciences","award":["2016-12M-1-002"],"award-info":[{"award-number":["2016-12M-1-002"]}]},{"name":"the National Key Research and Development Program of China","award":["2016YFC0901503"],"award-info":[{"award-number":["2016YFC0901503"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p><jats:italic>ETV6-ACSL6<\/jats:italic> is a fusion gene rarely reported in myeloid malignancies, and its clinical characteristics, proper treatment strategies, and effect on prognosis are poorly understood.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Sixteen patients with the <jats:italic>ETV6-ACSL6<\/jats:italic> fusion gene were identified, with a median age of 50\u2009years. Twelve patients were male. Clinical diagnoses included chronic eosinophilic leukemia, not otherwise specified, acute myeloid leukemia, and other types of myeloproliferative and myelodysplastic disorders. Ten out of 12 patients had increased levels of eosinophils, and four out of five had increased levels of basophils in peripheral blood. Treatment with tyrosine kinase inhibitors was ineffective. The prognosis of the patients was poor, with seven patients dying within 1 year.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Patients with the <jats:italic>ETV6-ACSL6<\/jats:italic> fusion gene mainly present with myeloproliferative and myelodysplastic disorders, typically with increased eosinophils and\/or basophils and poor survival. Intensive therapies such as allogenic stem cell transplantation should be an initial consideration for eligible patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13023-020-01478-6","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T12:02:53Z","timestamp":1595937773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["ETV6-ACSL6 fusion gene in myeloid neoplasms: clinical spectrum, current practice, and outcomes"],"prefix":"10.1186","volume":"15","author":[{"given":"Xia","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dao-bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7884-3073","authenticated-orcid":false,"given":"Xin-xin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,28]]},"reference":[{"issue":"6","key":"1478_CR1","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/sj.leu.2402121","volume":"15","author":"R Slater","year":"2001","unstructured":"Slater R, Drunen E, Kroes W, Weghuis DO, van den Berg E, Smit E, et al. t (7; 12)(q36; p13) and t (7; 12)(q32; p13)\u2013translocations involving ETV6 in children 18 months of age or younger with myeloid disorders. Leukemia. 2001;15(6):915.","journal-title":"Leukemia"},{"issue":"4","key":"1478_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/gcc.21918","volume":"51","author":"C Haferlach","year":"2012","unstructured":"Haferlach C, Bacher U, Schnittger S, Alpermann T, Zenger M, Kern W, et al. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events. Genes Chromosom Cancer. 2012;51(4):328\u201337.","journal-title":"Genes Chromosom Cancer"},{"key":"1478_CR3","first-page":"8324791","volume":"2016","author":"D Luca-Johnson","year":"2016","unstructured":"Luca-Johnson D, Ninfea JIR, Pearson L, Conant J, Bryant R, Zakai NA, et al. Myeloid neoplasms with t (5; 12) and ETV6-ACSL6 gene fusion, potential mimickers of myeloid neoplasm with PDGFRB rearrangement: case report with imatinib therapy and review of the literature. Case Rep Med. 2016;2016:8324791.","journal-title":"Case Rep Med"},{"issue":"1","key":"1478_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12935-018-0716-7","volume":"18","author":"X-X Cao","year":"2018","unstructured":"Cao X-X, Cai H, Mao Y-Y, Wu Q, Zhang L, Zhou D-B, et al. Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients. Cancer Cell Int. 2018;18(1):215.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"1478_CR5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/(SICI)1098-2264(199911)26:3<192::AID-GCC2>3.0.CO;2-E","volume":"26","author":"F Yagasaki","year":"1999","unstructured":"Yagasaki F, Jinnai I, Yoshida S, Yokoyama Y, Matsuda A, Kusumoto S, et al. Fusion of TEL\/ETV6 to a novel ACS2 in myelodysplastic syndrome and acute myelogenous leukemia with t (5; 12)(q31; p13). Genes Chromosom Cancer. 1999;26(3):192\u2013202.","journal-title":"Genes Chromosom Cancer"},{"issue":"5","key":"1478_CR6","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1182\/blood.V99.5.1776","volume":"99","author":"J Cools","year":"2002","unstructured":"Cools J, Mentens N, Odero MD, Peeters P, Wlodarska I, Delforge M, et al. Evidence for position effects as a variantETV6-mediated leukemogenic mechanism in myeloid leukemias with at (4; 12)(q11-q12; p13) or t (5; 12)(q31; p13). Blood. 2002;99(5):1776\u201384.","journal-title":"Blood"},{"issue":"6","key":"1478_CR7","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/sj.leu.2404194","volume":"20","author":"A Murati","year":"2006","unstructured":"Murati A, Adelaide J, Gelsi-Boyer V, Etienne A, Remy V, Fezoui H, et al. t (5; 12)(q23\u201331; p13) with ETV6-ACSL6 gene fusion in polycythemia vera. Leukemia. 2006;20(6):1175.","journal-title":"Leukemia"},{"issue":"1","key":"1478_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cancergencyto.2007.05.020","volume":"178","author":"Y Katsura","year":"2007","unstructured":"Katsura Y, Suzukawa K, Nanmoku T, Nemoto N, Machino T, Obara N, et al. Myelodysplastic syndrome accompanied by basophilia and eosinophilia with t (5; 12)(q31; p13). Cancer Genet Cytogenet. 2007;178(1):85\u20138.","journal-title":"Cancer Genet Cytogenet"},{"issue":"5","key":"1478_CR9","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3324\/haematol.2009.016345","volume":"95","author":"P Erben","year":"2010","unstructured":"Erben P, Gosenca D, M\u00fcller MC, Reinhard J, Score J, del Valle F, et al. Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis. Haematologica. 2010;95(5):738\u201344.","journal-title":"Haematologica"},{"key":"1478_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ehpc.2015.10.001","volume":"5","author":"RJ Su","year":"2016","unstructured":"Su RJ, Jonas BA, Welborn J, Gregg JP, Chen M. Chronic eosinophilic leukemia, NOS with t (5; 12)(q31; p13)\/ETV6-ACSL6 gene fusion: a novel variant of myeloid proliferative neoplasm with eosinophilia. Human Pathol Case Rep. 2016;5:6\u20139.","journal-title":"Human Pathol Case Rep"},{"key":"1478_CR11","doi-asserted-by":"publisher","unstructured":"Gosenca D, Erben P, Haferlach C, Schwerdtfeger R, Baurmann H, Bolz G, et al. Clinical and molecular heterogeneity of eosinophilia-associated myeloproliferative neoplasms with a translocation t (5; 12). Blood. 2009;114(22):4983. https:\/\/doi.org\/10.1182\/blood.V114.22.4983.4983.","DOI":"10.1182\/blood.V114.22.4983.4983"},{"key":"1478_CR12","doi-asserted-by":"publisher","unstructured":"Hock H, Shimamura A. ETV6 in hematopoiesis and leukemia predisposition. Seminars in Hematology. 2017;54(2):98\u2013104. https:\/\/doi.org\/10.1053\/j.seminhematol.2017.04.005.","DOI":"10.1053\/j.seminhematol.2017.04.005"},{"issue":"8","key":"1478_CR13","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1182\/blood.2019852418","volume":"134","author":"J Di Paola","year":"2019","unstructured":"Di Paola J, Porter CC. ETV6-related thrombocytopenia and leukemia predisposition. Blood. 2019;134(8):663\u20137.","journal-title":"Blood"},{"issue":"26","key":"1478_CR14","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1182\/blood-2015-02-580043","volume":"125","author":"SP Hunger","year":"2015","unstructured":"Hunger SP, Mullighan CG. Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine. Blood. 2015;125(26):3977\u201387.","journal-title":"Blood"},{"issue":"11","key":"1478_CR15","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3324\/haematol.2016.147496","volume":"101","author":"F Melazzini","year":"2016","unstructured":"Melazzini F, Palombo F, Balduini A, De Rocco D, Marconi C, Noris P, et al. Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia. Haematologica. 2016;101(11):1333\u201342.","journal-title":"Haematologica"},{"issue":"3","key":"1478_CR16","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1113\/JP272962","volume":"595","author":"BG Teodoro","year":"2017","unstructured":"Teodoro BG, Sampaio IH, Bomfim LH, Queiroz AL, Silveira LR, Souza AO, et al. Long-chain acyl-CoA synthetase 6 regulates lipid synthesis and mitochondrial oxidative capacity in human and rat skeletal muscle. J Physiol. 2017;595(3):677\u201393.","journal-title":"J Physiol"},{"issue":"2","key":"1478_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000086584","volume":"114","author":"M Kim","year":"2005","unstructured":"Kim M, Lim J, Lee A, Park G, Kim Y, Han K, et al. A case of chronic myelomonocytic leukemia with severe eosinophilia having t (5; 12)(q31; p13) with t (1; 7)(q10; p10). Acta Haematol. 2005;114(2):104\u20137.","journal-title":"Acta Haematol"},{"issue":"8","key":"1478_CR18","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.humpath.2009.02.011","volume":"40","author":"G Tang","year":"2009","unstructured":"Tang G, Woods LJ, Wang SA, Brettler D, Andersen M, Miron PM, et al. Chronic basophilic leukemia: a rare form of chronic myeloproliferative neoplasm. Hum Pathol. 2009;40(8):1194\u20139.","journal-title":"Hum Pathol"},{"issue":"3","key":"1478_CR19","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1182\/blood-2013-05-501312","volume":"122","author":"M Bj\u00f6rkholm","year":"2013","unstructured":"Bj\u00f6rkholm M, Kristinsson SY, Landgren O, Goldin LR. No familial aggregation in chronic myeloid leukemia. Blood. 2013;122(3):460\u20131.","journal-title":"Blood"},{"issue":"6","key":"1478_CR20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/ajh.23193","volume":"87","author":"G Helbig","year":"2012","unstructured":"Helbig G, Soja A, Bartkowska-Chrobok A, Kyrcz-Krzemie\u0144 S. Chronic eosinophilic leukemia-not otherwise specified has a poor prognosis with unresponsiveness to conventional treatment and high risk of acute transformation. Am J Hematol. 2012;87(6):643\u20135.","journal-title":"Am J Hematol"},{"issue":"8","key":"1478_CR21","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.leukres.2012.04.010","volume":"36","author":"E De Braekeleer","year":"2012","unstructured":"De Braekeleer E, Douet-Guilbert N, Morel F, Le Bris M-J, Basinko A, De Braekeleer M. ETV6 fusion genes in hematological malignancies: a review. Leuk Res. 2012;36(8):945\u201361.","journal-title":"Leuk Res"},{"issue":"4","key":"1478_CR22","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/bjh.14488","volume":"176","author":"NM Butt","year":"2017","unstructured":"Butt NM, Lambert J, Ali S, Beer PA, Cross NC, Duncombe A, et al. Guideline for the investigation and management of eosinophilia. Br J Haematol. 2017;176(4):553\u201372.","journal-title":"Br J Haematol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01478-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-020-01478-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01478-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T23:30:38Z","timestamp":1627428638000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01478-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1478"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01478-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,28]]},"assertion":[{"value":"6 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No ethical approval was required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from the reported patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}